Coronapod: new hope from COVID antiviral drugs



Coronapod: new hope from COVID antiviral drugs

Noah Baker and Heidi Ledford dig into new antivirals

Two new anti-viral pills have been shown to be safe and effective against COVID in clinical trials, according to recent press releases. The drugs, molnupiravir, developed by Merck and Ridgeback Biotherapeutics, and Paxlovid, developed by Pfizer both appear to significantly reduce hospitalisation in people with early COVID. Some researchers are quietly hopeful that these new weapons in the anti-COVID arsenal could have a big impact, in particular in parts of the world where vaccines are still not widely available, but there are a number of caveats. In this episode of Coronapod, we open the pill boxes and pick through the contents – asking how the drugs work, what side effects we might see and how, if at all, they might change the course of the pandemic.

News: COVID antiviral pills: what scientists still want to know

Never miss an episode: Subscribe to the Nature Podcast on Apple Podcasts, Google Podcasts, Spotify or your favourite podcast app. Head here for the Nature Podcast RSS feed.



Nature Careers


Products You May Like

Articles You May Like

LinkedIn adds Hindi to reach 500 million people in India
What’s Inside A Camel Hump?
Google workers in U.S. won’t return to office as expected on Jan. 10
Norwegian Wolf Now Classified as an Extinct Species
AWS adds user monitoring and A/B testing to CloudWatch